Atrial natriuretic peptide influence on nitric oxide system in kidney and heart

被引:22
作者
Costa, MD [1 ]
Elesgaray, R [1 ]
Loria, A [1 ]
Balaszczuk, AM [1 ]
Arranz, C [1 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiol, IQUIMEFA,CONICET, RA-1113 Buenos Aires, DF, Argentina
关键词
nitric oxide; nitric oxide synthase; atria; ventricle; renal medulla; renal cortex;
D O I
10.1016/j.regpep.2003.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial natriuretic peptide (ANP) and nitric oxide (NO) induce diuresis, natriuresis and diminish vascular tone. Our previous studies showed NO system is involved in ANP hypotensive effect. The aim was to investigate ANP effects on renal and cardiac NO-synthase (NOS) activity. Rats were divided into two groups: group 1, infused with saline (I h, 0.05 ml/min); group 11, received ANP bolus (5 mug/kg)+ANP infusion (I h, 0.2 mug/kg.min). NADPH-diaphorase activity (NADPH-d) was determined in kidney and heart. NOS catalytic activity was determined in renal medulla and cortex and cardiac atria and ventricle by measuring the conversion Of L-[(UC)-C-14]-arginine to L[(UC)-C-14]-citrulline. In group 1, NOS activity was determined in basal conditions and plus I muM ANP and in group 11, NOS activity was determined in basal conditions. NADPH-d was higher in group 11 than in group I in glomeruli, proximal tubule, cortical and medullar collecting duct, right atria and left ventricle. NOS activity was increased by in vitro ANP addition and, in vivo, ANP infusion in all the studied tissues. ANP treatment increases renal and cardiac NO synthesis. This effect would be independent on the hemodynamic changes induced by ANP. The activation of NO pathway would be one of the mechanisms involved in diuretic, natriuretic and hypotensive effects of ANP. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 51 条
[1]   Intrarenal dopamine: A key signal in the interactive regulation of sodium metabolism [J].
Aperia, AC .
ANNUAL REVIEW OF PHYSIOLOGY, 2000, 62 :621-647
[2]   A MECHANISM BY WHICH ATRIAL-NATRIURETIC-FACTOR MEDIATES ITS GLOMERULAR ACTIONS [J].
APPEL, RG ;
WANG, J ;
SIMONSON, MS ;
DUNN, MJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (06) :F1036-F1042
[3]  
Beltowski J, 1998, J PHYSIOL PHARMACOL, V49, P271
[4]  
Beltowski Jerzy, 2002, Med Sci Monit, V8, pRA39
[5]   DIVERSE BIOLOGICAL ACTIONS OF ATRIAL-NATRIURETIC-PEPTIDE [J].
BRENNER, BM ;
BALLERMANN, BJ ;
GUNNING, ME ;
ZEIDEL, ML .
PHYSIOLOGICAL REVIEWS, 1990, 70 (03) :665-699
[6]   ATRIAL-NATRIURETIC-FACTOR AND CGMP INHIBIT AMILORIDE-SENSITIVE NA+ TRANSPORT IN THE CULTURED RENAL EPITHELIAL-CELL LINE, LLC-PK1 [J].
CANTIELLO, HF ;
AUSIELLO, DA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) :852-860
[7]   Nitric oxide synthase: Role in the genesis of vascular disease [J].
Cooke, JP ;
Dzau, VJ .
ANNUAL REVIEW OF MEDICINE, 1997, 48 :489-509
[8]   Effects of dopamine and nitric oxide on arterial pressure and renal function in volume expansion [J].
Costa, MA ;
Loria, A ;
Marchetti, M ;
Balaszczuk, AM ;
Arranz, CT .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2002, 29 (09) :772-776
[9]   Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats [J].
Costa, MD ;
Bosc, LVG ;
Majowicz, MP ;
Vidal, NA ;
Balaszczuk, AM ;
Arranz, CT .
HYPERTENSION, 2000, 35 (05) :1119-1123
[10]  
DEFORSTERMANN U, 1991, BIOCHEM PHARMACOL, V42, P1849